NCT03442088: A reported trial by University Hospitals Cleveland Medical Center
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03442088 |
|---|---|
| Title | An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 1, 2018 |
| Completion date | Sept. 30, 2021 |
| Required reporting date | Sept. 30, 2022, midnight |
| Actual reporting date | Sept. 26, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |